HB 1050 Summary

• Exempts American Society of Addiction Medicine level 3.7 substance use treatment programs licensed by the Department of Health and Human Services from requiring a medical hospital license if they operate independently from a hospital.

• Changes terminology throughout the statute from "substance abuse" to "substance abuse/use disorder" to reflect current medical terminology.

• Updates notice procedures for license suspension or revocation to include electronic mail as a valid delivery method in addition to registered mail and personal delivery.

• Requires applicants and licensees to have 30 days after receiving written charges to submit a written request for an administrative hearing before license suspension or revocation takes effect.

• Maintains existing requirements for opioid treatment programs to obtain state licensure, federal certification, and DEA registration, and to submit controlled substance dispensing information to the state's prescription drug monitoring program.